Found 26 matching trials
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma PHASE4 This study is a one-arm exploratory clinical study of Disitamab Vedotin for...
Show More Location
Multiple Locations
Learn More & Join Trial
Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer PHASE1 This is a single-arm, open-label, Phase Ib/II clinical trial designed to ev...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of Disitam...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG) PHASE1 This is a single-center, open-label, dose-escalation phase I clinical study...
Show More Learn More & Join Trial
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer PHASE2 This is a Phase II/III, randomized, multicenter, open-label clinical trial ...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC) PHASE2 This is a single-arm, open, single-center clinical study to evaluate the ef...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma PHASE4 A multicenter, open, single arm, phase II clinical trial was designed for m...
Show More Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Learn More & Join Trial
RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC PHASE2 This is a prospective, open, single-center clinical study of RC48 combined ...
Show More Location
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Learn More & Join Trial
DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC PHASE1 This is a single-arm, exploratory clinical study....
Location
Multiple Locations
Learn More & Join Trial
Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer PHASE2 This study aims to evaluate the efficacy and safety of intravenous administ...
Show More Location
Shanxi Provincial Cancer Hospital
Learn More & Join Trial